Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 10, 2026 02:30 ET | Source: Custom Market Insights

[Latest] Global Viral Vaccine Cell Culture Media Market Size/Share Worth USD 3.5 Billion by 2035 at a 6.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, March 10, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Viral Vaccine Cell Culture Media Market Size, Trends and Insights By Cell...
March 09, 2026 15:00 ET | Source: FocusMax

FocusMax Cognitive Support Claims Evaluated: Latest 2026 Consumer Research Report on FocusMax Ingredients, Proprietary Blend Dosing, and Cognitive Supplement Research

2026 consumer research report evaluating FocusMax cognitive support claims, ingredient research, proprietary blend dosing, and pricing disclosures
March 09, 2026 14:17 ET | Source: TMates

TMates GLP-1 Weight Loss Program Claims Evaluated: 2026 Consumer Research Report on Compounded Semaglutide, Tirzepatide, Telehealth Weight-Loss Access, Pricing, and Verification Considerations

TMates GLP-1 claims evaluated: compounded semaglutide, tirzepatide telehealth access, pricing, provider structure, and consumer verification.
March 09, 2026 12:18 ET | Source: Research and Markets

Ixchiq (Valneva) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 09, 2026 (GLOBE NEWSWIRE) -- The "Ixchiq Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
March 09, 2026 09:00 ET | Source: Inspired Entertainment, Inc.

Inspired Entertainment Announces Multi-Year Extension of Virtual Sports Partnership with bet365

Inspired signs multi-year virtual sports extension with bet365
March 09, 2026 07:00 ET | Source: Xenon Pharmaceuticals Inc.

Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS)

X-TOLE2 met primary endpoint in both dose groups, including -53.2% median percent change (MPC) from baseline in monthly FOS frequency with 25 mg dose compared with -10.4% for placebo...
March 08, 2026 15:07 ET | Source: CafeCasino

No Deposit Bonus Canada 2026 Free Spins No Deposit by Cafe Casino

New York City, NY, March 08, 2026 (GLOBE NEWSWIRE) -- In the evolving Canadian gaming landscape of 2026, casino no deposit bonus campaigns are reshaping how players engage with regulated...
March 06, 2026 19:02 ET | Source: Peak Health Research

MagnesiumFreeze Sciatic Nerve Claims Evaluated: Consumer Research Report Examines Magnesium Niacinamide Relief Topical Cream Ingredients, NAD+ Science, and Sciatic Nerve Support Discussions

MagnesiumFreeze sciatic nerve claims examined: 2026 consumer research report on Magnesium Niacinamide Relief ingredients, NAD+ science, pricing.
March 06, 2026 15:05 ET | Source: Mind Vault

Mind Vault Brain Formula Claims Evaluated: 2026 Consumer Report Examines Cognitive Support Ingredient Research, Senior Memory Marketing, and What Adults 45+ Should Verify

2026 consumer report evaluates Mind Vault brain formula ingredient research, senior cognitive support claims, and key verification considerations
March 06, 2026 11:55 ET | Source: SleepZee

SleepZee Anti-Snoring Mouthpiece Consumer Report: 2026 Analysis of Mandibular Advancement Device Research, Snoring Reduction Claims, and What Buyers Should Verify

2026 consumer report examines SleepZee anti-snoring mouthpiece mandibular advancement research, snoring reduction claims, and buyer checklist.